Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

APS Accelerator modular systems, 208-230 V-, 50/60 Hz, 1800 VA, IVD, RX, Class 2 Laser Product,

FDA Recall Z-2755-2019 · Posted None

Recall StatusTerminated
Product CodeJQP
Date Initiated2018-09-07
Date Terminated2021-02-02
Product Quantity159 devices

Reason for Recall

The firm identified customer sites where modules which the safety pacemaker label is missing. Information regarding the label included in the Operations Manual has been updated to specify: 1) the risk of malfunction applies to anyone with a pacemaker who may work on these modules; 2) the minimum safety distance has increased to 200 mm (7.87") from transport mechanisms. Any person with a pacemaker must not get closer than this distance from modules axes.

Firm Action

On September 7, 2018, Abbott sent all affected consignees a "Product Correction Urgent - Immediate Action required" letter along with an "Attachment A" containing serial numbers. The letter informed consignees of the following: 1.Please be aware that personnel fitted with a pacemaker/implanted heart defibrillator must not handle or work on these modules at distances less than 200 mm even if the warning label is missing. 2. Your Abbott representative will be contacting you to schedule time to place a new hazard label on the APS modules. In the interim, please remove the last page of this letter and affix a copy of the label on the cover of these modules until the official pacemaker label is available. 3.Please review the attached Errata Sheet and save it with the Operations Manual for future reference regarding the safety distance required for pacemakers/implanted heart defibrillator. 4. Please retain this letter for your laboratory records. 5. If you or any of the health care providers you serve have any questions regarding this information, U.S. Customers please contact Customer Service at 1877 4ABBOTT (available 24 hours a day, 7 days a week). 6. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online at (http://www.fda.gov/MedWatch/report.htm), by mail (http://www.fda.gov/MedWatch/getforms.htm), by phone (18003321088), or by fax (1800FDA 0178).

Root Cause

Component change control

Distribution Pattern

US: TX, VA, AZ, NV, MA, LA, MN, PA, SC, NJ, NY, CA, IL, IN, WA, FL, TN, PA, KS, ND, NC, CT OUS: Argentina, Australia, Belgium, Canada, China, Denmark, France, Greece, Hong Kong, Ireland, Italy, New Zealand, Norway, Oman, Pakistan, Philippines, Portugal, Russia, Saudi Arabia, Singapore, Spain, Taiwan, Turkey, UAE, UK, Venezuela

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑